Adaptive Biotechnologies President, COO Julie Rubinstein disposes of $830,400 in common shares
Adaptive Biotechnologies President and COO Julie Rubinstein sold 35,643 shares on Oct. 9, Oct. 12, Oct. 13. Sales prices: $26.41, $25.35, $26.07, $25.5. * Holdings fell to 377,802 shares following the transactions. * Trades followed option exercises of 11,881 shares at $12.14 on each date. Disclaimer: This news brief w